| Yabe Yuichiro | Early Aggressive Intervention for Rheumatoid Arthritis Increases Rate of Remission Defined Using a Boolean Approach in Clinical Practice with Tocilizumab. |
| Yacyshyn Elaine | Hydroxychloroquine Retinopathy in Inflammatory Arthritis: A Retrospective Analysis in Canadian Patients. |
| | Patient-Driven On-Line Survey on Granulomatosis with Polyangiitis. |
| Yada Erika | Evidence for a Direct Role of Anti-Signal Recognition Particle Antibodies in the Pathogenesis of Necrotizing Myopathies. |
| Yadao Anthony | Health Care Resource Utilization Is Associated with Attack Frequency in Patients with Gouty Arthritis. |
| | Ambulatory Resource Utilization for Gouty Arthritis and Gouty Arthritis Attacks. |
| | Clinical Characteristics of Difficult-to-Treat Gout Patients: a Principal Components Analysis. |
| Yadin Ora | Race, Ethnicity and Gender Affect the Severity of Renal Outcomes in Patients with Pediatric Systemic Lupus Erythematosus: An Analysis of the CARRAnet Data At Baseline Visit. |
| Yagishita Naoko | Importance of E3 Ubiquitin Ligase Synoviolin In Fibrogenesis. |
| Yagita Hideo | Blockade of Delta-like1 Suppresses Osteoclastgenesis and Arthritis. |
| Yague Jordi | Clinical and Genetic Features of Autoinflammatory Syndromes in Hispanic Patients: The Chilean Experience. |
| Yair Shira | A Humanized Monoclonal Antibody Against a Surface Ligand of Mononuclear Cells Suppress Autoimmune Inflammatory Diseases by Upregulation of IL-10 Secretion. |
| Yajima Nobuyuki | Anti-CCP Titers Are Predictive of the Response to Biological Agents in Patients with Rheumatoid Arthritis. |
| Yalavarthi Srilakshmi | Vitamin D Deficiency, Interleukin 17, and Vascular Function in Rheumatoid Arthritis. |
| Yalcinkaya Yasemin | A Retrospective Analysis of Anti-TNF Treatment of 146 Ankylosing Spondylitis Patients According to Gender. |
| Yamada Akira | In Situ Immune Complex (MPO-anti MPO antibody) and Complement 3 cause Glomerular Capillary Injury in Human MPO-ANCA Associated Glomerulonephritis. |
| Yamada Hidehiro | Transcription Intermediary Factor (TIF)-1 Is a New Dermatomyositis Autoantigen. |
| Yamada Ryo | A Large-Scale Association Study Identified Multiple HLA-DRB1 Alleles Associated with Anti-Citrullinated Peptide Antibody Negative Rheumatoid Arthritis in Japanese. |
| Yamada Susumu | Tocilizumab Monotherapy Improves BONE Mineral Density AS Well AS TNF Blockers PLUS Methotrexate with Methotrexate-RESISTANT Activerheumatoid Arthritis. AN OPEN-Label RANDOMIZED CLINICAL TRIAL. T-BONE TRIAL. |
| | Tocilizumab Improves Arterial Stiffness Compared with Abatacept In Patients with TNF Blockers-Resistant Active Rheumatoid Arthritis.An Open Label Randomized Controlled Trial. |
| Yamada Taketo | A New Derivative of Roxithromycin Modulates Immunological Responses and Ameliorates Collagen-Induced Arthritis. |
| Yamaguchi Ken-ichi | Risk Factors for Positive Rheumatoid Factor Among 31,207 People without Rheumatologic Disorders. |
| | Safety and Efficacy of Mizoribine in Patients with Connective Tissue Diseases Other Than Rheumatoid Arthritis. |
| | A Quality Indicator for Osteoporosis in a Japanese Hospital. |
| Yamaguchi Yukie | A Peptide Derived From Endostatin Ameliorates Fibrosis Induced by TGF and Bleomycin in Multiple Pre-Clinical Models. |
| | A Membrane-Associated Adaptor Protein DOK5 Is Upregulated in SSc and Associated with IGFBP-5-Induced Fibrosis. |
| Yamaguci Ayako | Characterization of Anti Sjgren's Syndrome Nuclear Antigen-1 (SSNA-1) Novel Autoantibody in Patients with Primary Sjgren's Syndrome. |
| Yamamoto Kazuhiko | Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Japanese Rheumatoid Arthritis Patients with An Inadequate Response to Methotrexate. |
| | 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments: Golimumab, a Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy. |
| | A Large-Scale Association Study Identified Multiple HLA-DRB1 Alleles Associated with Anti-Citrullinated Peptide Antibody Negative Rheumatoid Arthritis in Japanese. |
| | Efficacy and Safety of Certolizumab Pegol without Methotrexate Co-Administration in Japanese Patients with Active Rheumatoid Arthritis. |
| | A Calcineurin Inhibitor FK506 Suppresses Joint Destruction in Patients with Early Rheumatoid Arthritis and Low Disease Activity. |
| | Golimumab, A Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks As Monotherapy in Patients with Active Rheumatoid Arthritis Despite DMARD Therapy: 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments. |
| | Contribution of a Kidney-Infiltrating CD4 T Cell Clone to Nephritis in Lupus-Prone Mice. |
| Yamamoto Shotaro | No Change in the Levels of PPD Reaction During Treatment with TNF Inhibitors in Rheumatoid Arthritis Patients in Japan, a Country with High Morbidity of Tuberculosis. |
| Yamamoto Tatsuhiro | Evaluation of 13c-Acetate Plus Lactulose Breath Test, a New Examination to Measure Intestinal Absorption in Patients with Systemic Sclerosis. |
| | Changes in Serum Receptor Activator for Nuclear Factor B Ligand and Osteoprotegerin After Glucocorticoid Therapy Reflect Regulation of Their Expression by Glucocorticoid in Osteoblasts in Vitro. |
| Yamamoto Tatsuya | Gene Polymorphisms of Signal Transducers and Activator of Transcription 4 and Tumor Necrosis Factor Receptor-Associated Factor 1 Predict Clinical Response to Disease-Modifying Anti-Rheumatic Drugs in Japanese Patients with Rheumatoid Arthritis. |
| Yamamoto Tetsuya | Inhibitory Effect of c-Fos/AP-1 Inhibitor T-5224 on the Levels of Cytokines and Chemokines in the Arthritic Lesion of Mice with Collagen-Induced Arthritis. |
| Yamamoto Yuka | Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Is Useful for the Visualization of Reticulo-Endotheliao System and Prediction of Steroid-Resistant Cases in Adult Onset of Still's Disease. |
| Yamana Jiro | T-Cell-Related Cytokines Are Inhibited in Response to Tocilizumab in Patients with Rheumatoid Arthritis in Contrast with TNF-Inhibitor. |
| Yamana Seizo | T-Cell-Related Cytokines Are Inhibited in Response to Tocilizumab in Patients with Rheumatoid Arthritis in Contrast with TNF-Inhibitor. |
| Yamanaka H. | Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, As Monotherapy or with Background Methotrexate in Japanese Patients with Rheumatoid Arthritis: A Phase 2/3 Long-Term Extension Study. |
| | Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, As Monotherapy in Japanese Patients with Active Rheumatoid Arthritis: A 12-Week Phase 2b Study. |
| | Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, As Monotherapy in Patients with Active Rheumatoid Arthritis: A Comparison Between Japanese and Global Populations Over 12 Weeks of Dosing in Phase 2b Studies. |
| Yamanaka Hisashi | Impact of Tocilizumab Therapy for Remission Quartet in Rheumatoid Arthritisthe Result of 104 Weeks Follow up Data of REACTION study. |
| | Risk Factors Associated with Incident Hip Fractures in 9,720 Japanese Patients with Rheumatoid Arthritis: A Prospective Observational Cohort Study. |
| | Classification of Two Subtypes in Adult-Onset Still's Disease. |
| | Efficacy and Safety of Certolizumab Pegol without Methotrexate Co-Administration in Japanese Patients with Active Rheumatoid Arthritis. |
| | A Large-Scale Association Study Identified Multiple HLA-DRB1 Alleles Associated with Anti-Citrullinated Peptide Antibody Negative Rheumatoid Arthritis in Japanese. |
| | Successful Maintenance of Remission Defined by the New ACR/EULAR Criteria Leads to Better Functional Outcomes in Rheumatoid Arthritis in Daily Practice, Especially in Patients with Early RA, Based on the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) Cohort. |
| | Discrepancy Between Boolean Remission and DAS28 Remission Is Dependent on the Differences in Number of Swollen Joints and Patient Global Assessment in Daily Practice, Based on the Institute of Rheumatology, Rheumatoid Arthritis (IORRA) Cohort. |
| | Golimumab, A Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks As Monotherapy in Patients with Active Rheumatoid Arthritis Despite DMARD Therapy: 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments. |
| | Greater Physical Dysfunction Is a Negative Predictor for Achieving Boolean-Based Remission in Patients with Rheumatoid Arthritis Treated with Tocilizumab. |
| | Impact of Tocilizumab Therapy After Switching From Tumor Necrosis Factor (TNF) inhibitors Prevention of Joint Damage by Tocilizumab in Patients with Inadequate Response to Anti-TNF Therapies. |
| | No Evidence of Increased Mortality in Rheumatoid Arthritis Patients Treated with Biologics: Results From a Multicenter Cohort in Japan. |
| | Atorvastatin Attenuates Skin Fibrosis Through the PI3K Pathway. |
| | Anti-CADM-140 Antibody, Ferritin and IL-18 Are Associated with Disease Activity of Interstitial Lung Disease in Anti-CADM-140 Antibody-Positive Dermatomyositis. |
| | Identification of Clinical and Genetic Factors That Influence the Response to Methotrexate in Japanese Rheumatoid Arthritis Patients: Genome-Wide Association Study. |
| | Notch Pathway Is Activated in Systemic Sclerosis (SSc). |
| | Ischemic Colitis (IC) Associated with Rheumatic Diseases; A Colonoscopic Study of 23 IC Cases. |
| | Urinary Free Light Chain Concentration Is Associated with Disease Activity and Response to Treatment in Proliferative Lupus Nephritis. |
| | Postmarketing Surveillance of Tocilizumab for Rheumatoid Arthritis In JapanFull Analysis Report of 7,901 Patients. |
| | Decreased Plasma Ghrelin Levels in Patients with Systemic Sclerosis. |
| | 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments: Golimumab, a Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy. |
| | Efficacy and Safety of Certolizumab Pegol Plus Methotrexate in Japanese Rheumatoid Arthritis Patients with An Inadequate Response to Methotrexate. |
| | Remission Induction by Etanercept (ETN) Plus Methotrexate (MTX) Combination Therapy Versus ETN Monotherapy in Patients with Active Rheumatoid Arthritis Despite MTX Treatment. |
| Yamano Yoshihisa | Importance of E3 Ubiquitin Ligase Synoviolin In Fibrogenesis. |
| Yamaoka Kunihiro | A Multi-Biomarker Disease Activity Score (VectraDA algorithm score) Reflects Clinical Disease Activity and Tracks Response in a Japanese Rheumatoid Arthritis Population Treated with Anti-TNF Therapy. |
| | Discontinuation of Adalimumab Without Functional and Structural Progress After Attaining Remission in Patients with Rheumatoid Arthritis. |
| | Dopamine D2-Like Receptor Signaling Inhibits Human Osteoclast Differentiation From Monocytes. |
| | Relevance of Involvement of Tofacitinib in T Cell Subsets to Clinical Courses in Patients with Rheumatoid Arthritis. |
| | Tofacitinib Reduces Interleukin-6 and Matrix Metalloproteinase-3 Production and Inhibits Cartilage Destruction in Rheumatoid Arthritis. |
| | Tofacitinib Reduces Interferon- and Interleukin-17 Production From CD4 T Cells in Patients with Rheumatoid Arthritis. |
| Yamasaki Masaomi | Clinical Characterization of Extensive Interstitial Lung Disease in Rheumatoid Arthritis Patients. |
| Yamasaki Satoshi | Evaluation of the Patients with Early Arthritis by 2010 RA Criteria in Conjunction with MRI of Wrists and Finger Joints. |
| | Functional Changes of Bone Marrow Derived Mesenchymal Stem Cell Through Adipogenesis. A Possible in Vitro Model of Bone Edema in Rheumatoid Arthritis. |
| Yamasaki Yoshioki | Transcription Intermediary Factor (TIF)-1 Is a New Dermatomyositis Autoantigen. |
| Yamasaki Yuichi | Measuring S100A12 and Vascular Endothelial Growth Factor Can Differentiate Familial Mediterranean Fever and Early Onset Sarcoidosis From Systemic Juvenile Idiopathic Arthritis. |
| | Can Long-Term Use of Tocilizumab Induce Drug-Free Remission in Systemic Juvenile Idiopathic Arhtritis Refractory to Steroid Therapy? |
| Yamazaki Hayato | Biological Agents in Rheumatoid Arthritis and Risk of Malignancy Results From the Nation-Wide Cohort Study in Japan. |
| Yan James | HM-018, An Oral Small Molecule JAK Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis (EAE) in Mice. |
| | A Novel, Highly Selective Syk Kinase Inhibitor Significantly Ameliorates the Severity of Arthritis in Rodents. |
| Yan Mei | Intra-Articular Injection of the Selective IB Kinase Inhibitor NEMO-Binding Peptide Ameliorates Collagen Induced Arthritis by Inducing Regulatory T Cells and Alternatively Activated Macrophages. |
| Yanaba Koichi | IL-10-Producing Regulatory B Cells (B10 cells) Inhibit Intestinal Injury In Mice. |
| | Serum Interleukin-9 Levels Are Increased In Patients with Systemic Sclerosis: Association with Lower Frequency and Severity of Pulmonary Fibrosis. |
| Yanagida Tamiko | Enhanced Expression of mRNA for Interleukin 6 and Tumor Necrosis Factor-Alpha In CD34 Cells of the Bone Marrow In Osteoarthritis. |
| Yanai Ryo | Differential Regulation of Serum Cytokine Profiles In Patients with Rheumatoid Arthritis Treated with Tocilizumab: Possible Involvement of Macrophage Migration Inhibitory Factor. |
| | Anti-CCP Titers Are Predictive of the Response to Biological Agents in Patients with Rheumatoid Arthritis. |
| Yanes James | Subsequent Therapy of Patients with Biologic Response Modifiers or Disease-Modifying Antirheumatic Drugs After Coccidioidomycosis. |
| Yang Eva | Evidence That HLA-B27-Induced Endoplasmic Reticulum (ER) Stress Produces Pro- and Anti-Osteoclastogenic Cytokines in Rats with Spondyloarthritis-Like Disease. |
| Yang Hyung-In | Synergy Between Adiponectin and Interleukin-1 on the Expression of Interleukin-6, Interleukin-8, and Cyclooxygenase-2 in Fibroblast-Like Synoviocytes. |
| | Anti-TNF Agents May Accelerate the Remodeling of Hip Cartilage in Ankylosing Spondylitis. |
| Yang Il Hwan | A Novel SYK Specific Inhibitor for the Treatment of Rheumatoid Arthritis. |
| Yang Jui-Chen | Rheumatologists' Benefit-Risk Preferences for Biologic Treatments for Rheumatoid Arthritis. |
| Yang Kai | Molecular Imaging of Rheumatoid, Psoriatic and Osteoarthritis in the Hand. |
| Yang Lihua | Niemann-Pick Type C2 Protein As a Negative Regulator of Innate Immunity: Inflammatory Cytokines and Eicosanoids. |
| Yang Lisong | IRF5 Activation in Monocytes of SLE Patients Is Triggered by Circulating Autoantigens Independent of Type I IFN. |
| Yang PingAr | Fucosylation Inhibitor, 2-D-Gal, Promotes Human Synovial Fibroblast Apoptosis and Is a Potent Suppressor of Arthritis in a TNF- Tg Mouse Model In Vivo. |
| | A Novel Role for Vitamin D in Immunosenescence: Is Enough Too Much for Nave CD8 T Cells? |
| | IL-23 Upregulates IRF5 and Polarizes Inflammatory M1 Macrophages to Promote Inflammation in a Mouse Model of Arthritis. |
| | Rebalancing the IL-23/Th17 Axis and Regulatory T Cells in Arthritis by Depleting IRF5 IL-23 M1 Macrophages Using An Anti-Human DR5 Antibody. |
| Yang Shuo | Derivation and Validation of An Infection Risk Score to Predict the Risk of Serious Infections for Rheumatoid Arthritis Patients. |
| Yang Xiaoning | HM-018, An Oral Small Molecule JAK Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis (EAE) in Mice. |
| Yano Toshiro | Clinical Efficacy of Infliximab Is Maximized When Both Circulating TNF and IL-6 Are Suppressed In the Treatment of Rheumatoid ArthritisResults From the RISING Study. |
| Yao Chunxiang | A Novel Human Autoantigen Induces T and B Cell Responses in Patients with Antibiotic-Refractory Lyme Arthritis. |
| Yao Jianhua | Fully Quantitative Syndesmophyte Measurement in Ankylosing Spondylitis Using Computed Tomography: Reliability of Volume and Height Measures. |
| | Fully Quantitative Syndesmophyte Measurement in Ankylosing Spondylitis Using Computed Tomography: Validity of Volume and Height Measures. |
| Yao Lawrence | Fully Quantitative Syndesmophyte Measurement in Ankylosing Spondylitis Using Computed Tomography: Validity of Volume and Height Measures. |
| | Fully Quantitative Syndesmophyte Measurement in Ankylosing Spondylitis Using Computed Tomography: Reliability of Volume and Height Measures. |
| Yao Qingping | Tumor Necrosis Factor Receptor Associated Periodic Fever Syndrome: A Case Series with Characteristic Features. |
| | Characterization of a New Category of Autoinflammatory Disease Associated with Nucleotide Oligomerization Domain2 Gene Mutations: An Expanded Cohort Study. |
| Yao Yihong | Identification of microRNA-31 as a Novel Regulator Contributing to Impaired IL-2 Production in T cells From Patients With Systemic Lupus Erythematosus. |
| | Identification of Activated Cytokine Pathways in the Blood of Systemic Lupus Erythematosus, Myositis, Rheumatoid Arthritis, and Scleroderma Patients. |
| | Systemic Lupus Erythematosus, Myositis, Rheumatoid Arthritis, and Scleroderma Patients Share Activation of a Common Type I Interferon Pathway. |
| YAP Desmond YH | Binding of Serum IgG to Human Mesangial Cells and Its Correlation with Disease Activity in Patients with Lupus Nephritis. |
| Yaqub Aaliya | Effect of the ETA Selective Endothelin Receptor Antagonist Ambrisentan on Digital Ulcers in Patients with Systemic Sclerosis: Results of a Prospective Pilot Study. |
| Yarlagadda Sushma | DNA Methylation Regulates Gene Expression in CD4CD28- T Cells Through Micrornas. |
| Yasuda Shinsuke | Role of Apolipoprotein B100 and Oxidized Low-Density Lipoprotein in Anti-beta2 Glycoprotein I Induced Tissue Factor Expression on Monocytes. |
| | HLA-DRB501:05 Is a Risk Factor for Systemic Sclerosis with Interstitial Lung Disease. |
| Yasukawa Masaki | Analysis of the Bioactive Molecules That Promote the Induction of Human Tolerogenic Dendritic Cells. |
| | Lysophosphatidylcholine Enhances Suppressive Function of Human Naturally Occurring Regulatory T Cells Through TGF-Beta Production. |
| Yasumura Junko | Can Long-Term Use of Tocilizumab Induce Drug-Free Remission in Systemic Juvenile Idiopathic Arhtritis Refractory to Steroid Therapy? |
| Yasuoka Hidekata | A Membrane-Associated Adaptor Protein DOK5 Is Upregulated in SSc and Associated with IGFBP-5-Induced Fibrosis. |
| | Impaired In Vivo Neovascularization Capacity of Endothelial Progenitor Cells In Patients with Systemic Sclerosis. |
| Yates Allen | Serum Cystatin C Is Affected by Inflammation and Renal Dysfunction in Patients with Systemic Lupus Erythematosus. |
| Yau Ivanna | Vessel Remodeling in Childhood Primary CNS Vasculitis: Impact of Corticosteroid Therapy. |
| | Distinct Phenotypical Clusters In Childhood Inflammatory Brain Diseases: Implications for Diagnostic Evaluation. |
| Yau Michelle S. | Heritability and Linkage of Radiographic Progression of Hip and Knee Osteoarthritis: Results From the Longitudinal Component of the Genetics of Generalized Osteoarthritis Study. |
| Yau Wing Hoi | Steroid Injection for Plantar Fasciitisa Placebo-Controlled Trial. |
| Yavuz Sule | Dual Effects of Testosterone in Behcet's Disease: Implications for a Role in Disease Pathogenesis. |
| Yazawa K. | Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, As Monotherapy in Patients with Active Rheumatoid Arthritis: A Comparison Between Japanese and Global Populations Over 12 Weeks of Dosing in Phase 2b Studies. |
| Yazdany Jinoos | Effect of Health Insurance Coverage on Quality of Care in SLE. |
| | Cardiovascular Risk Assessment and Management in a Nationally Representative Sample of Routine Ambulatory Visits for Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus. |
| | Physical Activity, Body Composition, and Cognitive Impairment Among Women with Systemic Lupus Erythematosus. |
| | Cardiovascular Disease and Cognitive Dysfunction in Systemic Lupus Erythematosus. |
| | Effects of Pediatric-Onset Systemic Lupus Erythematosus on Final Linear Height: Evidence From a Large Observational Cohort. |
| | Quality of Care for Common Comorbidities Among Patients with Rheumatoid Arthritis: An Analysis of HEDIS Data. |
| | Extra-Articular Manifestations of Rheumatoid Arthritis in An Ethnically Diverse Cohort: Prevalence and Clinical Associations. |
| | Increased Disease Activity Measure in Systemic Lupus Erythematosus Is Adversely Associated with Pregnancy and Pregnancy Outcomes. |
| Yazici Hasan | Some Manifestations Disappear Earlier Than Others in Behcet's Syndrome. |
| | A Possible Source of Error in the Method of Cancer Risk Estimation in Patients with Rheumatoid Arthritis. |
| | The Table-1 p Value Issue; Baseline Group Comparison Is Inappropriately Omitted in Non-Randomized Studies. |
| | Management and Prognosis of Non-Pulmonary Large Arterial Disease in Behcet's Syndrome: A Reappraisal of 25 Patients From a Single Center. |
| Yazici Yusuf | RAPID3 Remission Vs New ACR Rheumatoid Arthritis Remission Criteria: RAPID3 Has Similar Utility and May Be Used in Everyday Clinical Care. |
| | Comparative Effectiveness and Time to Response Among Abatacept, Adalimumab, Etanercept and Infliximab for the Treatment of Rheumatoid Arthritis in a Real World Routine Care Registry. |
| | A Self-Report RADAI (Rheumatoid Arthritis Disease Activity Index) Count of Painful Joints Can Be Informative in Patients with Rheumatic Diseases Other Than Rheumatoid Arthritis. |
| | Patients Whose Global Estimates Are Higher Than Their Physician's Global Estimates Are More Likely to Be Female, Have Fewer Years of Formal Education, and Higher RAPID3 (Routine Assessment of Patient Index Data) Scores. |
| | Assessment of Disease Activity in Behcet Disease: Comparison of Behcet's Disease Current Activity Form (bdcaf), Behcet's Syndrome Activity Score (bsas) and Routine Assessment of Patient Index Data (rapid) 3 Scores. |
| | Efficacy of Tanezumab Compared with Non-Steroidal Anti-Inflammatory Drugs in Patients with Knee or Hip Osteoarthritis (NCT00809354). |
| | A Possible Source of Error in the Method of Cancer Risk Estimation in Patients with Rheumatoid Arthritis. |
| | Comparative Efficacy and Tolerability of Biologic Therapies in Early Rheumatoid Arthritis Utilizing a Bayesian Approach. |
| | Association of ACR Clinical Responses with CDAI (Clinical Disease Activity Index) and RAPID3 (Routine Assessment of Patient Index Data 3) Indices of Disease Activity in Rheumatoid Arthritis Patients Treated with Certolizumab Pegol Plus Methotrexate. |
| | Scores for Sleep, Anxiety, and Depression on the Multidimensional Health Assessment Questionnaire (MDHAQ) in the Patient-Friendly HAQ Format Are Higher Than for Any of the 8 Traditional HAQ Queries to Identify Problems in Patients with Rheumatic Diseases. |
| | Difference of Manifestations and Treatment Among Behcet's Syndrome Patients in the United States and Japan. |
| | Disease Activity Levels and Treatment Patterns Amongst Ethnic Minority Rheumatoid Arthritis Consortium Patients. |
| | Routine Assessment of Patient Index Data-3 (RAPID3) Is Informative in Patients with All Rheumatic Diseases to Depict Patient-Reported Information As Quantitative Data, Rather Than As Narrative Descriptions. |
| | Ethnic Minority Rheumatoid Arthritis Consortium: A Clinical Registry of Minority Patients with Rheumatoid Arthritis. |
| | Assesment of Disease Activity in Ankylosing Spondylitis: Comparison of Rapid3, Basdai, Basfi, and Asdas Scores in Routine Care. |
| | Low Levels of Formal Education Generally Are As Significant As High Age and Long Duration of Disease to Identify Poor Clinical Status in Patients with Most Rheumatic Diseases. |
| | Clinical Response At Months 16 Can Predict Likelihood of Achieving Remission in Abatacept Plus Methotrexate-Treated Patients with Early Rheumatoid Arthritis. |
| | 2010 American College of Rheumatology/European League Against Rheumatism Rheumatoid Arthritis Criteria Classifies 67 of Systemic Lupus Erythematosus and 38 of Psoriatic Arthritis As Rheumatoid Arthritis: Implications for Real World Use. |
| Ye S.Q. | Decreased Expression of Nicotinamide Phosphoribosyltransferase (NAMPT) in Active Juvenile Idiopathic Arthritis Patients Receiving Methotrexate. |
| Ye Xiangyang | Serum Uric Acid Testing Patterns In Gout Patients: A Need for Improved Monitoring. |
| Yeaw Jason | Comparing Costs of Tumor Necrosis Factor Blockers Per Treated Patient for Psoriatic Arthritis Using Real-World Data in US Managed Care. |
| | Costs of Tumor Necrosis Factor Blockers Per Treated Rheumatoid Arthritis Patient Using Real-World Drug Data in US Commercially-Insured Population. |
| Yee Chee-Seng | Development of Damage and Death in a Large Cohort of SLE Patients. |
| | Longitudinal Assessment of SLE Disease Activity: BILAG-2004, SLEDAI-2000 or Both? |
| | The BILAG-2004 Systems Tallya Novel Way of Analysing the BILAG-2004 Scores. |
| Yeganeh Ladan | Is Dietary Intake of Patients with Systemic Lupus Erythematosus Adequate? |
| Yeh Li-tain | Pharmacokinetics, Efficacy and SAFETY of Lesinurad, a Novel URAT1 Inhibitor, In Individuals with Mild to Moderate Renal Impairment. |
| Yelin Edward | Increased Disease Activity Measure in Systemic Lupus Erythematosus Is Adversely Associated with Pregnancy and Pregnancy Outcomes. |
| | Quality of Care for Common Comorbidities Among Patients with Rheumatoid Arthritis: An Analysis of HEDIS Data. |
| | Physical Activity, Body Composition, and Cognitive Impairment Among Women with Systemic Lupus Erythematosus. |
| | Cardiovascular Risk Assessment and Management in a Nationally Representative Sample of Routine Ambulatory Visits for Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus. |
| | Long-Term Mental Health Outcomes in Pediatric-Onset Systemic Lupus Erythematosus. |
| | Effect of Health Insurance Coverage on Quality of Care in SLE. |
| | Identifying Obesity in Rheumatoid Arthritis: Current BMI Definition of Obesity Does Not Accurately Reflect Body Composition. |
| Yelin Edward H. | Cardiovascular Disease and Cognitive Dysfunction in Systemic Lupus Erythematosus. |
| | C-Reactive Protein Associated with Depression in Patients with Rheumatoid Arthritis. |
| Yeremenko Nataliya | Identification of Robust and Disease-Specific Stromal Alterations in Spondyloarthritis Synovitis. |
| | Serum Biomarkers to Predict Clinical Response in Proof-of-Concept Trials in Spondyloarthritis. |
| Yerges-Armstrong Laura | Heritability and Linkage of Radiographic Progression of Hip and Knee Osteoarthritis: Results From the Longitudinal Component of the Genetics of Generalized Osteoarthritis Study. |
| | Association of Candidate Single Nucleotide Polymorphisms with Radiographic Knee Osteoarthritis in African-Americans: Data From the Genetic Components of Knee Osteoarthritis Study. |
| Yeung Rae SM | Characterization of Active Joint Count Trajectories in Juvenile Idiopathic Arthritis. |
| | Use of IntraArticular Steroid Injection in a Large Cohort of Children with Oligoarticular Juvenile Idiopathic Arthritisthe ReACCh Out Study. |
| | Treatment Delay in Kawasaki Diseasethe Role of Non-Traditional Risk Factors. |
| Yew Margaret | Non-Calcified Coronary Plaque in Systemic Lupus Erythematosus Quantitative Analysis. |
| Yi Nengjun | Transforming Growth Factor- Receptor One Variant Is Associated with Constitutively Decreased Transforming Growth Factor- Signaling and Risk for Systemic Sclerosis. |
| Yigla Mordehai | Efficacy and Safety of Intravenous Cyclophosphamide In the Treatment of Scleroderma Lung Disease: 7-Year Follow-up. |
| Yildiz Yasar | Evaluation of Circulating Endothelial and Platelet Microparticles In Men with Ankylosing Spondylitis. |
| Yilmaz Sedat | Assesment of Disease Activity in Ankylosing Spondylitis: Comparison of Rapid3, Basdai, Basfi, and Asdas Scores in Routine Care. |
| | Assessment of Disease Activity in Behcet Disease: Comparison of Behcet's Disease Current Activity Form (bdcaf), Behcet's Syndrome Activity Score (bsas) and Routine Assessment of Patient Index Data (rapid) 3 Scores. |
| Yilmaz V. | Genome-Wide Expression Profiling of CD14 Monocytes in Behcet's Disease: An Upregulated TGF-b Signaling and N-Methyltransferase Activity. |
| Yilmaz Zevcet | Frequency of Pulmonary Arterial Hypertension Is Not Increased in Takayasu's Arteritis. |
| Yim Cheuk-Wan | Infliximab Is Associated with Improvement in Arterial Stiffness in Patients with Early Rheumatoid Arthritisa Randomized Trial. |
| Yim Cheuk-wan | Low Serum Levels of Soluble Receptor for Advanced Glycation End Products Are Associated with Increased Augmentation Index in Patients with Early Rheumatoid Arthritis. |
| Yin Hongen | Matriptase Dificency and Primary Sjogren Syndrome Induction: From Patients to Mice. |
| Ying Jun | Immunochip Genotyping of 1,884 Systemic Sclerosis Cases and 4,325 Controls Reveals Novel Associations. |
| | Behavior, Executive and Perceived Neuropsychological Functioning with Childhood-Onset Systemic Lupus ErythematosusResults of a Best-Friend Controlled Study. |
| | A Functional IRF5 Variant Predicts Prognosis in Patients with Systemic Sclerosis. |
| | The Pediatric Automated Neuropsychological Assessment Metrics Has Reproducibility and Criterion Validity in Childhood-Onset Lupus. |
| | HLA DQB103:02 Is a Marker for Severity of Interstitial Lung Disease in Systemic Sclerosis. |
| Ying King Yee | Effect of Raloxifene, a Selective Estrogen Receptor Modulator, on Disease Activity, Flare and Vascular Biomarkers in Patients with Systemic Lupus Erythematosus (SLE): A 12-Month Double-Blinded Randomized Controlled Trial. |
| | Infliximab Is Associated with Improvement in Arterial Stiffness in Patients with Early Rheumatoid Arthritisa Randomized Trial. |
| | Low Serum Levels of Soluble Receptor for Advanced Glycation End Products Are Associated with Increased Augmentation Index in Patients with Early Rheumatoid Arthritis. |
| Yip Jonathan | Clinical-Pathological Correlates of Proliferative Lesions in Lupus Nephritis. |
| Yip Paul | Incidence and Standardized Incidence Ratio (SIR) of Suicide in Southern Chinese Patients with Rheumatic Diseases in Hong Kong, China: 19992010. |
| Yli-Kerttula Timo | Correlation of 18fFDG PET Assessments with Disease Activity and Markers of Inflammation in Patients with Early Rheumatoid Arthritis Following Initiation of Antirheumatic Therapy. |
| Yocum David E. | Rheumatologists' Benefit-Risk Preferences for Biologic Treatments for Rheumatoid Arthritis. |
| | A Plasmablast Molecular Biomarker for Reduced Clinical Benefit From Anti-CD20 Therapy in Rheumatoid Arthritis. |
| Yoguim Marcelo I. | Measurement of Pain Perception in Children and Adolescents with Musculoskeletal Pain. |
| Yokoe Isamu | Detection of Left Ventricular Regional Dysfunction by Using Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients without Cardiac Symptoms; Comparison Between Non-Biologic DMARDs and Biologics Groups. |
| Yokogawa Naoto | New Index to Assess the Improvement From the Worst Rheumatoid Arthritis Activity without Formal Joint Count. |
| | To Screen Remission without Formal Joint Count: Analysis of Routine Assessment of Patient Index Data 3 in Japanese National Database. |
| | Response to Hydroxychloroquine in Japanese Patients with Cutaneous Lupus Erythematosus Using the Cutaneous Lupus Erythematosus Disease Area and Severity Index. |
| Yokosawa Masahiro | Evaluation of Activity, Making Diagnosis and Prediction of Future Bone Destruction by Using Low Field Compact Magnetic Resonance Imaging Machine in Patients with Rheumatoid Arthritis. |
| Yokota Kazuhiro | The Pattern-Recognition Receptor NOD1 Promotes Production of Inflammatory Mediators in Different Cell Types of the Synovium in Rheumatoid Arthritis. |
| Yokota Shumpei | Mycophenolate Mofetil (MMF) Versus Azathioprine As Maintenance Therapy Combined with Monthly Intravenous Cyclophsophamide (IVCY) in Juvenile Lupus Nephritis. |
| | Radiological Evaluation of Systemic Juvenile Idiopathic Arthritis Treated with Tocilizumab, An Anti-IL6 Receptor Monoclonal Antibody. |
| Yokoyama Waka | Chemerin Activates Fibroblast-Like Synoviocytes In Patients with Rheumatoid Arthritis. |
| Yomogida Kentaro | Cell Penetrating Recombinant Foxp3 Protein Enhances Treg Function, Suppresses Th17 Cells and Ameliorate Arthritis. |
| Yona Eliyahu | Activation of c-Jun N-Terminal Kinase and Extracellular Signal-Regulated Kinase Predicts Damage in Systemic Lupus Erythematosus. |
| Yonemoto Yukio | Direct Comparison of Four Biologics in Biologic-nave Rheumatoid Arthritis Patients. |
| Yong Harry | Nitrated Nucleosome Levels in Patients with Systemic Lupus ErythematosusAssociations with Disease Activity. |
| | Nitrated Nucleosome Levels in Patients with Systemic Lupus Erythematosus Associations with Ethnicity and Autoantibody Status. |
| Yoo Bin | Efficacy of Combined Treatment with Allopurinol and Benzbromarone in Gout Patients with Chronic Renal Impairment. |
| | The Role of Sufficient Starting Dose of Steroids in Adult-Onset Still's Disease. |
| | The Influence of Interleukin-32 on Osteoclastogenesis, with a Focus on Fusion-Related Genes. |
| Yoo Dae-Hyun | Free Interleukin 18 As a Predictor of Remission and Flare up in Adult-Onset Still's Disease Patients. |
| | What Factors Affect Discordance Between Physicians and Patients in Assessments of Global Health in Rheumatoid Arthritis? |
| | Do Patients with Elderly-Onset Rheumatoid Arthritis Have Severe Functional Disability? |
| Yoo Myung Chul | Synergy Between Adiponectin and Interleukin-1 on the Expression of Interleukin-6, Interleukin-8, and Cyclooxygenase-2 in Fibroblast-Like Synoviocytes. |
| Yoo Wan-Hee | Inhibitory Effects of 1`,2`-Dihydrorotenone On Osteoclast Differentiation and Bone Resorption. |
| | Interesting Roles of IL-1 in Osteoclast Differentiation. |
| Yood Robert A. | Characterization and Management of Infusion Reactions in Refractory Chronic Gout (RCG) Treated with Pegloticase (PGL). |
| Yoon Bo Young | Do Patients with Elderly-Onset Rheumatoid Arthritis Have Severe Functional Disability? |
| | What Factors Affect Discordance Between Physicians and Patients in Assessments of Global Health in Rheumatoid Arthritis? |
| | Treatment of Chemotherapy-Related Arthropathy with Disease Modifying Antirheumatic Drugs: Results of An Open-Labeled Multicenter Pilot Study. |
| Yoon Chong-Hyeun | Prevalence and Associated Factors for Asymptomatic Pulmonary Arterial Hypertension in Patients with Systemic Lupus Erythematosus. |
| Yoon Chong-Hyun | Serum Leptin Levels Are Associated with the Presence of Syndemophytes in Male Patients with Ankylosing Spondylitis. |
| Yoon Grace | Clinical Predictors Associated with Severe Radiographic Sacroilitis in Axial Spondyloarthritis. |
| Yoon Hosung | Ultrasonographic Evaluation of Hand and Wrist in Systemic Lupus Erythematosus without Arthralgia. |
| | Prevalence and Associated Factors for Asymptomatic Pulmonary Arterial Hypertension in Patients with Systemic Lupus Erythematosus. |
| | Serum Leptin Levels Are Associated with the Presence of Syndemophytes in Male Patients with Ankylosing Spondylitis. |
| | Apolipoprotein M Polymorphism Is a Novel Risk Factor for Dyslipidemia in Rheumatoid Arthritis: A Possible Link Between Disease Susceptibility and Dyslipidemia. |
| Yoshida Hiroto | IL-6 Blockade Augments the Therapeutic Effect of MTX in Mice with Glucose-6-Phosphate Isomerase-Induced Arthritis. |
| Yoshida Kazuki | Tocilizumab and Tumor Necrosis Factor Inhibitors in Biologic Switchers: Similar Drug Survival and Safety with Different Infection Profile in Routine Practice. |
| | Difference of Manifestations and Treatment Among Behcet's Syndrome Patients in the United States and Japan. |
| Yoshida Kohsuke | TNF Modulates the Expression of Circadian Clock Genes in Rheumatoid Synovial Cells. |
| Yoshifuji Hajime | Clinical Features and Treatment of Dermatomyositis Patients with Anti-CADM-140 (melanoma differentiation-associated protein 5: MDA5) Antibody; Recommendation of Combined Immunosuppressive Therapy with Intensive Intravenous Cyclophosphamide. |
| Yoshikawa Hideki | Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Improves a Bone Resorption Marker in Postmenopausal Women with Rheumatoid Arthritis. |
| | Association of Pinch Strength with Hand Dysfunction, Finger Deformities and Contact Points In Patients with Rheumatoid Arthritis. |
| | Enhanced Expression of mRNA for Interleukin 6 and Tumor Necrosis Factor-Alpha In CD34 Cells of the Bone Marrow In Osteoarthritis. |
| | Comparison of Cytokine Levels in the Synovial Joint Fluid Between Rapidly Destructive Coxopathy, Hip Osteoarthritis, Rheumatoid Arthritis, and Hip Oseteonecrosis. |
| Yoshimi Ryusuke | Bach1 Regulates Osteoclastogenesis Via Heme Oxgenase-1 Dependent and Independent Pathways. |
| | Ultrasonography Is a Potent Tool for Prediction of Ongoing Joint Destruction During Clinical Remission of Rheumatoid Arthritis. |
| Yoshimoto Keiko | Abnormalities in a JAK-STAT Pathway Are Involved in the Aberrant Production of IL-6 by BAFF-Stimulated Peripheral Monocytes of Patients with Primary Sjgren's Syndrome. |
| Yoshinari Natalino H. | Abnormal Morphology and Excessive Synthesis of Collagen V Affects Skin Thickness and Disease Activity in Systemic Sclerosis. |
| Yoshinari Toru | 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments: Golimumab, a Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy. |
| | Clinical Efficacy of Infliximab Is Maximized When Both Circulating TNF and IL-6 Are Suppressed In the Treatment of Rheumatoid ArthritisResults From the RISING Study. |
| | Golimumab, A Human Anti-TNF Monoclonal Antibody, Administered Subcutaneously Every Four Weeks As Monotherapy in Patients with Active Rheumatoid Arthritis Despite DMARD Therapy: 52-Week Results of Clinical, Radiographic and Pharmacokinetic Assessments. |
| Yoshio Taku | No Evidence of Increased Mortality in Rheumatoid Arthritis Patients Treated with Biologics: Results From a Multicenter Cohort in Japan. |
| | The Intrathecal Production of IL-6, IL-8, IP-10, MCP-1 and G-CSF Increases More Highly Than the Serum Production in Patients with Central Neuropsychiatric Lupus Erythematosus. |
| Yoshitaka Teruhito | SH3BP2 Cherubism Gain-of-Function Mutation Exacerbates Inflammation and Bone Erosion in Collagen Induced Arthritis. |
| Yoshiura Koh-ichiro | Proteasome Disability Syndrome: An Analysis of the Pathogenesis of a New Autoinflammatory Syndrome, Nakajo-Nishimura Syndrome. |
| You Daniel | Clinical Correlates of CENP-A and CENP-B Antibodies in a Large Cohort of Systemic Sclerosis Patients. |
| You Min | Switching of Biologic Disease-Modifying Antirheumatic Drugs During the First Year in Patients with Rheumatoid Arthritis in a Real-World Setting. |
| | Real-World Switching Patterns in Rheumatoid Arthritis Patients Receiving Abatacept, Adalimumab, Etanercept or Infliximab As Second-Line Biologic Therapy. |
| Youinou Pierre | A Step Toward New Diagnostic Criteria in Sjgren's Syndrome: Contribution of Major Salivary Gland Ultrasonography and Blood B-Cell Subset Profiling. |
| Youinou Pierre Y. | Diagnostic Validity of Major Salivary Gland Ultrasonography for Sjogren's Syndrome: Echostructure, Gland Size and Dppler Waveform Analysis. |
| Young Adam | Safety and Efficacy of Etanercept Over Five Years in a Large, UK Observational Cohort. |
| Young Daniel | Mathematical Modeling of Interleukin-6 Signaling Inhibition: Comparative Efficiency of Different Intervention Strategies. |
| Young David | A Transcriptional Profile Present in CD4 T-Cells of Patients with Undifferentiated Arthritis Predicts the Future Development of Seronegative Rheumatoid Arthritis and Implicates IL-6 in Disease Evolution. |
| Young Deborah | IL-21R Is Required for the Systemic Accumulation of Activated B and T Lymphocytes in MRLlprMice. |
| Young Jason R. | Serum Uric Acid Testing Patterns In Gout Patients: A Need for Improved Monitoring. |
| Young Nicholas | A Chimeric Human-Mouse Model of Sjogren's Syndrome. |
| | ZAS3 Is Overexpressed in Peripheral Blood Mononuclear Cells in Systemic Lupus Erythematosus Patients and Is Regulated by Estrogen: A Cause of the Dysreguated IL-2 Response? |
| Young Nicholas A. | Estrogen Stimulation of Endosomal Toll-Like Receptor Expression Lowers the Threshold of Activation in Peripheral Blood Mononuclear Cells and Contributes to the Gender Bias of Systemic Lupus Erythematosus. |
| Yousaf Wajeeha | Defining Clinical Remission and Inactive Disease in Juvenile Systemic Lupus Erythematosus. |
| Yousefi Charlene | Development and Usability Testing of ANSWER: A Web-Based Methotrexate Decision Aid for Patients with Rheumatoid Arthritis. |
| Youssef Sally | Imaging As An Outcome Measure in Early Inflammatory Arthritis: Monitoring Disease Activity and Patients' Response to Therapy Using Ultrasonography. |
| Yow Eric | A Secondary Analysis of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Study Shows That Atorvastatin Therapy Reduces Progression of Carotid Intima Medial Thickening in Pubertal SLE Patients with Higher C Reactive Protein. |
| | CD146 Endothelial Progenitor Cell Number Increases Following 36 Months of Atorvastatin Therapy in Children and Adolescents with SLE: The Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Cohort. |
| Ytterberg Jimmy | Identification of Shared Citrullinated Potentially Immunological Targets in the Lungs and Joints of Patients with Rheumatoid Arthritis. |
| Ytterberg Steven R. | Distribution of Large Artery Lesions in Takayasu's Arteritis Compared to Giant Cell Arteritis. |
| | Increased Mortality in Giant Cell Arteritis with Large Vessel Disease: A Population-Based Cohort Study. |
| | Serum Proteins Reflecting Inflammation, Injury, and Repair As Biomarkers of Disease Activity in ANCA-Associated Vasculitis. |
| | Genome-Wide Association Study of Dermatomyositis Reveals Shared Genetic Risk Factors with Other Autoimmune Diseases. |
| | Relapses Among Patients with Giant Cell Arteritis. |
| | Type I Interferon-Related Biomarkers Predict Clinical Disease Activity in Inflammatory Myositis. |
| | Are Patients with ANCA-Associated Vasculitis Entered In Clinical Trials Representative of Patients Followed In Observational Cohorts? |
| | Extended Follow-up of Treatment with Rituximab Versus Cyclophosphamide for Remission-Induction of ANCA-Associated Vasculitis: Which Subsets Are At Greatest Risk for Flare? |
| Yu Andrew | Uncontrolled Serum Uric Acid Is Associated with An Increased Risk of Developing Renal Disease In Veterans with Gout. |
| | Uncontrolled Serum Uric Acid In Veteran Gout Patients Is Associated with a Higher Risk of Diabetes. |
| Yu Chack-Yung | Increased Frequency of Complement C4B Deficiency in Rheumatoid Arthritis (RA): Interaction with the Shared Epitope (SE). |
| | Association of Androgen Receptor Gene Polymorphism with Damage in Systemic Lupus Erythematosus. |
| | Risk Alleles of SLE Associated IL10 SNPs Conferred Differential Binding to Transcription Factors. |
| Yu Cheng | Modeling Human Rheumatoid Arthritis In Non-Human Primate: Type II Collagen Induced Arthritis In Cynomolgus Macaques. |
| Yu Cheuk-Man | Low Serum Levels of Soluble Receptor for Advanced Glycation End Products Are Associated with Increased Augmentation Index in Patients with Early Rheumatoid Arthritis. |
| | Infliximab Is Associated with Improvement in Arterial Stiffness in Patients with Early Rheumatoid Arthritisa Randomized Trial. |
| Yu Fang | Polymorphisms in N-Acetyltransferase 2 Impact Rheumatoid Arthritis Risk Due to Cigarette Smoking in African Americans. |
| Yu Jianghong | N-Acetylcysteine Improves Disease Activity by Blocking the Mammalian Target of Rapamycin in T Cells of Lupus Patients. |
| Yu Ka Lung | Performance of Complement C3, C4 and Anti-dsDNA Antibody in Predicting Disease Flare in Individual Organ Systems in Systemic Lupus Erythematosus: An Analysis of Data From 6035 Clinical Visits. |
| | Seasonal Variation in Mortality of Six Rheumatic Diseases in Hong Kong, China: An Analysis of 2772 Deaths. |
| | Performance of Complement C3, C4 and Anti-dsDNA Antibody in Predicting Disease Flare in Systemic Lupus Erythematosus: An Analysis of Data From 6035 Clinical Visits. |
| | Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients with Systemic Lupus Erythematosus. |
| Yu Shawn | Serum Uric Acid Testing Patterns In Gout Patients: A Need for Improved Monitoring. |
| Yu Shui Lian | Infliximab Is Associated with Improvement in Arterial Stiffness in Patients with Early Rheumatoid Arthritisa Randomized Trial. |
| | Low Serum Levels of Soluble Receptor for Advanced Glycation End Products Are Associated with Increased Augmentation Index in Patients with Early Rheumatoid Arthritis. |
| Yu Shui-Lian | Upregulated High Mobility Group Box One Acts in Synergy with Danger Signals Through the Activation of of p38 Mitogen-Activated Protein Kinases to Promote Inflammation in Patients with Lupus Nephritis. |
| Yu Yiding | Prevalence and Treatment Patterns of Psoriatic Arthritis in the Health Improvement Network. |
| Yu Yiyun | Leptin Promotes Th17 Responses. |
| | Fasting Expands Regulatory T Cells in Lupus Mice. |
| Yu Yongjuan | A Novel, Highly Selective Syk Kinase Inhibitor Significantly Ameliorates the Severity of Arthritis in Rodents. |
| Yu Youjun | HM-018, An Oral Small Molecule JAK Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis (EAE) in Mice. |
| Yu Yue | Vimentin Suppresses the Production of Reactive Oxygen Species and the Antimicrobial Response Via p47phox. |
| Yuan Jian-Min | Mortality Due to Coronary Heart Disease and Kidney Disease Among Middle-Aged and Elder Men and Women with Gout In the Singapore Chinese Health Study. |
| Yuan Weian | Therapeutic Massage on Pain Relief for Fibromyalgia: A Systematic Review and Meta-Analysis. |
| Yuan Weijia | Effects of Fasudil Treatment on Lupus Pathogenesis in NZB/W F1 Female Mice. |
| Yudoh Kazuo | Antigenic Targets and Pathogenicity of Anti-Endothelial Cell Antibodies in Kawasaki Disease. |
| Yukawa Naoichiro | Clinical Features and Treatment of Dermatomyositis Patients with Anti-CADM-140 (melanoma differentiation-associated protein 5: MDA5) Antibody; Recommendation of Combined Immunosuppressive Therapy with Intensive Intravenous Cyclophosphamide. |
| Yun Huifeng | Adherence with Intravenous Zoledronic Acid and Ibandronate for Osteoporosis Among U.S. Medicare Beneficiaries. |
| | Does Medication Adherence Itself Confer Fracture Protection? An Investigation of the Healthy Adherer Effect In Observational Data. |
| | Fractures and Mortality in Relation to Different Osteoporosis Treatments. |
| Yung Susan | Binding of Serum IgG to Human Mesangial Cells and Its Correlation with Disease Activity in Patients with Lupus Nephritis. |
| | Inhibition of Hyaluronan Synthesis with 4-Methylumbelliferone In NZBWF1/J Mice Is Associated with Improved Renal Function and Reduced Renal Inflammation. |
| Yurdakul Selen | Impairment of the Elastic Properties of Aorta and the Carotid Artery System in Patients with Takayasu's Arteritis. |
